{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:00:56Z","timestamp":1794006056719,"version":"4.8.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["222849\/Z\/21\/Z"],"award-info":[{"award-number":["222849\/Z\/21\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Hodge Foundation Early Career Clinical Academic Grant, Healthcare Education Improvement Wales (HEIW) Welsh Clinical Academic Track (WCAT) Fellowship","id":[{"id":"https:\/\/ror.org\/009cpky53","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NINDS K08 - 1K08NS13677501A1"],"award-info":[{"award-number":["NINDS K08 - 1K08NS13677501A1"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Child Neurologist Career Development Program","id":[{"id":"https:\/\/ror.org\/02xjhr934","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH137160"],"award-info":[{"award-number":["R01MH137160"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL151190"],"award-info":[{"award-number":["R01 HL151190"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL160089"],"award-info":[{"award-number":["R01 HL160089"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute for Health and Care Research (NIHR) Oxford Health Biomedical Research Centre","id":[{"id":"https:\/\/ror.org\/0187kwz08","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Hodge Centre for Translational Neuroscience"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Timothy syndrome is a multisystemic genetic disorder, classically characterised by prolonged QT interval and subsequent cardiac arrhythmias, neurodevelopmental disorders including developmental delay and autism and syndactyly or hip dysplasia. It is caused by variants in the\n                    <jats:italic>CACNA1C<\/jats:italic>\n                    gene, which encodes the widely expressed Ca\n                    <jats:sub>v<\/jats:sub>\n                    1.2 voltage-gated calcium channel. Since its characterisation in 2004, the number of variants in\n                    <jats:italic>CACNA1C<\/jats:italic>\n                    associated with Timothy syndrome has expanded. With advances in sequencing and the inclusion of\n                    <jats:italic>CACNA1C<\/jats:italic>\n                    in genomic screening, further variants have been identified presenting with incomplete features of Timothy syndrome or further aligned phenotypes, which are inconsistent with the original description. In the absence of a formal nomenclature, these presentations have been reported in a proliferation of ill-defined terms, e.g. Atypical Timothy Syndrome. At the same time, advances in knowledge and therapeutics have improved morbidity and life expectancy for these individuals when appropriately identified and managed. Here, we present guidelines for the diagnosis of individuals presenting with variants in\n                    <jats:italic>CACNA1C<\/jats:italic>\n                    , developed by an international panel of experts through Delphi consensus with the involvement of the\n                    <jats:italic>CACNA1C<\/jats:italic>\n                    community. We formalise the language around syndromic presentations linked to\n                    <jats:italic>CACNA1C<\/jats:italic>\n                    variants, reassert and demarcate the classical Timothy syndrome phenotype and provide a structured co-produced definition for CACNA1C-Related Disorder. Finally, we present minimum expected standards of clinical care for individuals with CACNA1C-Related Disorder or Timothy syndrome, with implications for long-term management and improved outcomes for affected individuals.\n                  <\/jats:p>","DOI":"10.1038\/s41431-026-02178-8","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T18:38:11Z","timestamp":1783622291000},"page":"1611-1621","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Timothy syndrome and CACNA1C-Related Disorder: first international language and management guidelines consensus statement"],"prefix":"10.1038","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1731-6039","authenticated-orcid":false,"given":"Jack F. G.","family":"Underwood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine W.","family":"Timothy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly","family":"Tyroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0393-6835","authenticated-orcid":false,"given":"Rebecca J.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivy E.","family":"Dick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey S.","family":"Pitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Tunbridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anwar","family":"Baban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3393-3494","authenticated-orcid":false,"given":"Nicola A. L.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6857-8904","authenticated-orcid":false,"given":"Georgia","family":"Sarquella Brugada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic","family":"Abrams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Timothy Syndrome Alliance (TSA)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Muir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Muir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meg","family":"McLaughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galina","family":"Gardiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Bresnahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achsah","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Ziegler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"key":"2178_CR1","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/0735-1097(94)00318-K","volume":"25","author":"ML Marks","year":"1995","unstructured":"Marks ML, Whisler SL, Clericuzio C, Keating M. A new form of long QT syndrome associated with syndactyly. J Am Coll Cardiol. 1995;25:59\u201364.","journal-title":"J Am Coll Cardiol"},{"key":"2178_CR2","first-page":"54","volume":"60","author":"H Reichenbach","year":"1992","unstructured":"Reichenbach H, Meister EM, Theile H. [The heart-hand syndrome. A new variant of disorders of heart conduction and syndactylia, including osseous changes in hands and feet. Kinderarzt Prax. 1992;60:54\u20136.","journal-title":"Kinderarzt Prax"},{"key":"2178_CR3","doi-asserted-by":"publisher","unstructured":"Splawski I, Timothy KW, Sharpe LM, Decher N, Kumar P, Bloise R, et al. CaV1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell Cell Press, 2004 p. 19\u201331. https:\/\/doi.org\/10.1016\/j.cell.2004.09.011","DOI":"10.1016\/j.cell.2004.09.011"},{"key":"2178_CR4","unstructured":"Orphanet: Timothy syndrome. 2026. Available from: https:\/\/www.orpha.net\/en\/disease\/detail\/65283"},{"key":"2178_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-024-03445-x","volume":"19","author":"KW Timothy","year":"2024","unstructured":"Timothy KW, Bauer R, Larkin KA, Walsh EP, Abrams DJ, Gonzalez Corcia C, et al. A natural history study of Timothy syndrome. Orphanet J Rare Dis. 2024;19. 433.","journal-title":"Orphanet J Rare Dis"},{"key":"2178_CR6","doi-asserted-by":"publisher","first-page":"8089","DOI":"10.1073\/pnas.0502506102","volume":"102","author":"I Splawski","year":"2005","unstructured":"Splawski I, Timothy KW, Decher N, Kumar P, Sachse FB, Beggs AH, et al. Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations. Proc Natl Acad Sci USA. 2005;102:8089\u201396.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2178_CR7","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1161\/CIRCGENETICS.113.000138","volume":"6","author":"NJ Boczek","year":"2013","unstructured":"Boczek NJ, Best JM, Tester DJ, Giudicessi JR, Middha S, Evans JM, et al. Exome sequencing and systems biology converge to identify novel mutations in the L-type calcium channel, CACNA1C, linked to autosomal dominant long QT syndrome. Circ Cardiovasc Genet. 2013;6:279\u201389.","journal-title":"Circ Cardiovasc Genet"},{"key":"2178_CR8","doi-asserted-by":"crossref","unstructured":"Gardner RJMK, Crozier IG, Binfield AL, Love DR, Lehnert K, Gibson K, et al. Penetrance and expressivity of the R858H CACNA1C variant in a five-generation pedigree segregating an arrhythmogenic channelopathy. Mol Genet Genomic Med. 2019;7. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30345660\/","DOI":"10.1002\/mgg3.476"},{"key":"2178_CR9","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1161\/CIRCULATIONAHA.118.035070","volume":"138","author":"SM Hosseini","year":"2018","unstructured":"Hosseini SM, Kim R, Udupa S, Costain G, Jobling R, Liston E, et al. Reappraisal of reported genes for sudden arrhythmic death. Circulation. 2018;138:1195\u2013205.","journal-title":"Circulation"},{"key":"2178_CR10","doi-asserted-by":"publisher","unstructured":"Rodan LH, Spillmann RC, Kurata HT, Lamothe SM, Maghera J, Jamra RA, et al. Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations. Genet Med. 2021;1\u201311. https:\/\/doi.org\/10.1038\/s41436-021-01232-8","DOI":"10.1038\/s41436-021-01232-8"},{"key":"2178_CR11","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1002\/ajmg.a.40657","volume":"176","author":"X Bozarth","year":"2018","unstructured":"Bozarth X, Dines JN, Cong Q, Mirzaa GM, Foss K, Lawrence Merritt J, et al. Expanding clinical phenotype in CACNA1C-related disorders: from neonatal onset severe epileptic encephalopathy to late-onset epilepsy. Am J Med Genet A. 2018;176:2733.","journal-title":"Am J Med Genet A"},{"key":"2178_CR12","doi-asserted-by":"publisher","unstructured":"Bauer R, Timothy KW, Golden A. Update on the molecular genetics of timothy syndrome. Front Pediatr. 2021;9. https:\/\/doi.org\/10.3389\/fped.2021.668546","DOI":"10.3389\/fped.2021.668546"},{"key":"2178_CR13","doi-asserted-by":"publisher","first-page":"541","DOI":"10.3390\/children11050541","volume":"11","author":"L Cipriano","year":"2024","unstructured":"Cipriano L, Piscopo R, Aiello C, Novelli A, Iolascon A, Piscopo C. Expanding the phenotype of the CACNA1C-associated neurological disorders in children: systematic literature review and description of a novel mutation. Children. 2024;11:541.","journal-title":"Children"},{"key":"2178_CR14","doi-asserted-by":"publisher","unstructured":"Levy RJ, Timothy KW, Underwood JFG, Hall Jeremy, Bernstein JA, Pa\u0219ca SP. A cross-sectional study of the neuropsychiatric phenotype of CACNA1C-related disorder. Pediatr Neurol. 2022;102542. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2022.10.013","DOI":"10.1016\/j.pediatrneurol.2022.10.013"},{"key":"2178_CR15","unstructured":"Napolitano C, Priori SG CACNA1C-Related Disorders. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews\u00ae. Seattle (WA): University of Washington, Seattle; 2024. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1403\/"},{"key":"2178_CR16","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/s41586-024-07310-6","volume":"628","author":"X Chen","year":"2024","unstructured":"Chen X, Birey F, Li M-Y, Revah O, Levy R, Thete MV, et al. Antisense oligonucleotide therapeutic approach for Timothy syndrome. Nature. 2024;628:818\u201325.","journal-title":"Nature"},{"key":"2178_CR17","doi-asserted-by":"publisher","first-page":"116","DOI":"10.5662\/wjm.v11.i4.116","volume":"11","author":"P Nasa","year":"2021","unstructured":"Nasa P, Jain R, Juneja D. Delphi methodology in healthcare research: How to decide its appropriateness. World J Methodol. 2021;11:116\u201329.","journal-title":"World J Methodol"},{"key":"2178_CR18","first-page":"377","volume":"20","author":"MA Walsh","year":"2018","unstructured":"Walsh MA, Turner C, Timothy KW, Seller N, Hares DL, James AF, et al. A multicentre study of patients with Timothy syndrome. EP Eur. 2018;20:377\u201385.","journal-title":"EP Eur"},{"key":"2178_CR19","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1016\/j.clinph.2019.09.003","volume":"130","author":"C Po\u2019","year":"2019","unstructured":"Po\u2019 C, Zordan R, Vecchi M, Cerutti A, Sartori S, Trevisson E, et al. Photosensitive epilepsy and long QT: expanding Timothy syndrome phenotype. Clin Neurophysiol J Int Fed Clin Neurophysiol. 2019;130:2134\u20136.","journal-title":"Clin Neurophysiol J Int Fed Clin Neurophysiol"},{"key":"2178_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2019.04.005","volume":"62","author":"C Colson","year":"2019","unstructured":"Colson C, Mittre H, Busson A, Leenhardt A, Denjoy I, Fressard V, et al. Unusual clinical description of adult with Timothy syndrome, carrier of a new heterozygote mutation of CACNA1C. Eur J Med Genet. 2019;62. 103648.","journal-title":"Eur J Med Genet"},{"key":"2178_CR21","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.jacep.2017.08.007","volume":"4","author":"KA Dufendach","year":"2018","unstructured":"Dufendach KA, Timothy K, Ackerman MJ, Blevins B, Pflaumer A, Etheridge S, et al. Clinical outcomes and modes of death in Timothy syndrome: a multicenter international study of a rare disorder. JACC Clin Electrophysiol. 2018;4:459\u201366.","journal-title":"JACC Clin Electrophysiol"},{"key":"2178_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.634655","volume":"9","author":"AA Nugud","year":"2021","unstructured":"Nugud AA, ELkholy NM, Omar AA, Qazi A, Tzivinikos C, Chencheri N, et al. Case report: expanding the phenotypic spectrum of Timothy syndrome type 1: a sporadic case with a de novo CACNA1C pathogenic variant and segmental ileal dilatation. Front Pediatr. 2021;9. 634655.","journal-title":"Front Pediatr"},{"key":"2178_CR23","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.yjmcc.2015.01.002","volume":"80","author":"K Wemh\u00f6ner","year":"2015","unstructured":"Wemh\u00f6ner K, Friedrich C, Stallmeyer B, Coffey AJ, Grace A, Zumhagen S, et al. Gain-of-function mutations in the calcium channel CACNA1C (Cav1.2) cause non-syndromic long-QT but not Timothy syndrome. J Mol Cell Cardiol. 2015;80:186\u201395.","journal-title":"J Mol Cell Cardiol"},{"key":"2178_CR24","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1002\/ajmg.a.34355","volume":"158A","author":"J Gillis","year":"2012","unstructured":"Gillis J, Burashnikov E, Antzelevitch C, Blaser S, Gross G, Turner L, et al. Long QT, syndactyly, joint contractures, stroke and novel CACNA1C mutation: expanding the spectrum of timothy syndrome. Am J Med Genet A. 2012;158A:182\u20137.","journal-title":"Am J Med Genet A"},{"key":"2178_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-025-01195-w","volume":"18","author":"RN Stringer","year":"2025","unstructured":"Stringer RN, Tang X, Jurkovicova-Tarabova B, Murphy M, Liedl KR, Weiss N. Functional characterization of a novel de novo CACNA1C pathogenic variant in a patient with neurodevelopmental disorder. Mol Brain. 2025;18. 26.","journal-title":"Mol Brain"},{"key":"2178_CR26","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/cge.14180","volume":"102","author":"AR Lipman","year":"2022","unstructured":"Lipman AR, Fan X, Shen Y, Chung WK. Clinical and genetic characterization of CACNA1A-related disease. Clin Genet. 2022;102:288\u201395.","journal-title":"Clin Genet"},{"key":"2178_CR27","doi-asserted-by":"publisher","first-page":"S59","DOI":"10.1111\/epi.14935","volume":"60","author":"M Wolff","year":"2019","unstructured":"Wolff M, Brunklaus A, Zuberi SM. Phenotypic spectrum and genetics of SCN2A-related disorders, treatment options, and outcomes in epilepsy and beyond. Epilepsia. 2019;60:S59\u201367.","journal-title":"Epilepsia"},{"key":"2178_CR28","doi-asserted-by":"publisher","first-page":"S77","DOI":"10.1111\/epi.16319","volume":"60","author":"E Gardella","year":"2019","unstructured":"Gardella E, M\u00f8ller RS. Phenotypic and genetic spectrum of SCN8A-related disorders, treatment options, and outcomes. Epilepsia. 2019;60:S77\u201385.","journal-title":"Epilepsia"},{"key":"2178_CR29","doi-asserted-by":"publisher","unstructured":"Yu L, Neves R, Bos MM, Tester DJ, Sardana M, Giudicessi JR, et al. Evaluation of CACNA1C-positive patients evaluated in a tertiary genetic heart rhythm clinic. J Cardiovasc Transl Res. 2025 Available from: https:\/\/doi.org\/10.1007\/s12265-025-10638-7","DOI":"10.1007\/s12265-025-10638-7"},{"key":"2178_CR30","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.ijcard.2016.06.081","volume":"220","author":"AP Landstrom","year":"2016","unstructured":"Landstrom AP, Boczek NJ, Ye D, Miyake CY, De la Uz CM, Allen HD, et al. Novel long QT syndrome-associated missense mutation, L762F, in CACNA1C-encoded L-type calcium channel imparts a slower inactivation tau and increased sustained and window current. Int J Cardiol. 2016;220:290\u20138.","journal-title":"Int J Cardiol"},{"key":"2178_CR31","doi-asserted-by":"publisher","first-page":"ehaf784.2648","DOI":"10.1093\/eurheartj\/ehaf784.2648","volume":"46","author":"MN Brogger","year":"2025","unstructured":"Brogger MN, Cazon Varela L, De La Higuera Romero L, Fernandez Fernandez X, Amor-Salamanca A, Cardenas Reyes I, et al. Associated phenotypes of pathogenic CACNA1C variants in a large cohort of patients undergoing genetic testing. Eur Heart J. 2025;46:ehaf784.2648.","journal-title":"Eur Heart J"},{"key":"2178_CR32","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1093\/europace\/euu063","volume":"16","author":"M Fukuyama","year":"2014","unstructured":"Fukuyama M, Wang Q, Kato K, Ohno S, Ding WG, Toyoda F, et al. Long QT syndrome type 8: novel CACNA1C mutations causing QT prolongation and variant phenotypes. Europace. 2014;16:1828\u201337.","journal-title":"Europace"},{"key":"2178_CR33","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1016\/j.hrthm.2010.08.026","volume":"7","author":"E Burashnikov","year":"2010","unstructured":"Burashnikov E, Pfeiffer R, Barajas-Mart\u00ednez H, Delp\u00f3n E, Hu D, Desai M, et al. Mutations in the cardiac L-type calcium channel associated with inherited J-wave syndromes and sudden cardiac death. Heart Rhythm J Heart Rhythm Soc. 2010;7:1872\u201382.","journal-title":"Heart Rhythm J Heart Rhythm Soc"},{"key":"2178_CR34","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.hrthm.2021.12.032","volume":"19","author":"V Novelli","year":"2022","unstructured":"Novelli V, Memmi M, Malovini A, Mazzanti A, Liu N, Yanfei R, et al. Role of CACNA1C in Brugada syndrome: prevalence and phenotype of probands referred for genetic testing. Heart Rhythm. 2022;19:798\u2013806.","journal-title":"Heart Rhythm"},{"key":"2178_CR35","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1161\/CIRCRESAHA.110.224279","volume":"108","author":"C Napolitano","year":"2011","unstructured":"Napolitano C, Antzelevitch C. Phenotypical manifestations of mutations in the genes encoding subunits of the cardiac voltage-dependent L-type calcium channel. Circ Res. 2011;108:607\u201318.","journal-title":"Circ Res"},{"key":"2178_CR36","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1161\/CIRCULATIONAHA.106.668392","volume":"115","author":"C Antzelevitch","year":"2007","unstructured":"Antzelevitch C, Pollevick GD, Cordeiro JM, Casis O, Sanguinetti MC, Aizawa Y, et al. Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation. 2007;115:442.","journal-title":"Circulation"},{"key":"2178_CR37","doi-asserted-by":"publisher","first-page":"8611","DOI":"10.3390\/ijms21228611","volume":"21","author":"D Endres","year":"2020","unstructured":"Endres D, Decher N, R\u00f6hr I, Vowinkel K, Domschke K, Komlosi K, et al. New Cav1.2 channelopathy with high-functioning autism, affective disorder, severe dental enamel defects, a short QT interval, and a novel CACNA1C loss-of-function mutation. Int J Mol Sci. 2020;21:8611.","journal-title":"Int J Mol Sci"},{"key":"2178_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-017-1180-1","volume":"15","author":"Y Chen","year":"2017","unstructured":"Chen Y, Barajas-Martinez H, Zhu D, Wang X, Chen C, Zhuang R, et al. Novel trigenic CACNA1C\/DES\/MYPN mutations in a family of hypertrophic cardiomyopathy with early repolarization and short QT syndrome. J Transl Med. 2017;15. 78.","journal-title":"J Transl Med"},{"key":"2178_CR39","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1093\/eurheartj\/ehab687","volume":"43","author":"R Walsh","year":"2022","unstructured":"Walsh R, Adler A, Amin AS, Abiusi E, Care M, Bikker H, et al. Evaluation of gene validity for CPVT and short QT syndrome in sudden arrhythmic death. Eur Heart J. 2022;43:1500\u201310.","journal-title":"Eur Heart J"},{"key":"2178_CR40","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1007\/s00395-014-0446-5","volume":"109","author":"DM B\u00e9ziau","year":"2014","unstructured":"B\u00e9ziau DM, Barc J, O\u2019Hara T, Le Gloan L, Amarouch MY, Solnon A, et al. Complex Brugada syndrome inheritance in a family harbouring compound SCN5A and CACNA1C mutations. Basic Res Cardiol. 2014;109:446.","journal-title":"Basic Res Cardiol"},{"key":"2178_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.1021009","volume":"9","author":"J Borb\u00e1s","year":"2022","unstructured":"Borb\u00e1s J, V\u00e1mos M, Hategan L, Han\u00e1k L, Farkas N, Szak\u00e1cs Z, et al. Geno- and phenotypic characteristics and clinical outcomes of CACNA1C gene mutation associated Timothy syndrome, \u2018cardiac only\u2019 Timothy syndrome and isolated long QT syndrome 8: a systematic review. Front Cardiovasc Med. 2022;9. 1021009.","journal-title":"Front Cardiovasc Med"},{"key":"2178_CR42","unstructured":"Boiteux C, Chauveau S, Gardey K, Sebbag L, Ditac G, Cazeneuve C, et al. Arrhythmogenic cardiomyopathy is a new phenotype associated with the CACNA1C p.Arg518Cys (R518C) Variant. JACC Clin Electrophysiol. 0(0). Available from: https:\/\/www.jacc.org\/doi\/abs\/10.1016\/j.jacep.2025.06.039"},{"key":"2178_CR43","first-page":"560","volume":"9","author":"NR Einhorn","year":"2023","unstructured":"Einhorn NR, Patel RS, Bennett JL, McDonald TV. Hypertrophic cardiomyopathy and long QT syndrome in cardiac-only Timothy syndrome. Hear Case Rep. 2023;9:560\u20134.","journal-title":"Hear Case Rep"},{"key":"2178_CR44","doi-asserted-by":"publisher","unstructured":"Kelu Bisabu K, Zhao J, Mokrane AE, Segura \u00c9, Marsolais M, Grondin S, et al. Novel gain-of-function variant in CACNA1C associated with Timothy syndrome, multiple accessory pathways, and noncompaction cardiomyopathy. Circ Genomic Precis Med. 2020;707\u20139. https:\/\/doi.org\/10.1161\/CIRCGEN.120.003123","DOI":"10.1161\/CIRCGEN.120.003123"},{"key":"2178_CR45","doi-asserted-by":"crossref","unstructured":"Gakenheimer-Smith L, Meyers L, Lundahl D, Menon SC, Bunch TJ, Sawyer BL, et al. Expanding the phenotype of CACNA1C mutation disorders. Mol Genet Genomic Med. 2021;9:e1673.","DOI":"10.1002\/mgg3.1673"},{"key":"2178_CR46","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGEN.119.002534","volume":"12","author":"SI Estes","year":"2019","unstructured":"Estes SI, Ye D, Zhou W, Dotzler SM, Tester DJ, Bos JM, et al. Characterization of the CACNA1C-R518C missense mutation in the pathobiology of long-QT syndrome using human induced pluripotent stem cell cardiomyocytes shows action potential prolongation and L-type calcium channel perturbation. Circ Genom Precis Med. 2019;12. e002534.","journal-title":"Circ Genom Precis Med"},{"key":"2178_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10370","volume":"7","author":"IE Dick","year":"2016","unstructured":"Dick IE, Joshi-Mukherjee R, Yang W, Yue DT. Arrhythmogenesis in Timothy Syndrome is associated with defects in Ca2+-dependent inactivation. Nat Commun. 2016;7. 10370.","journal-title":"Nat Commun"},{"key":"2178_CR48","doi-asserted-by":"publisher","DOI":"10.1085\/jgp.202213209","volume":"154","author":"MA Bamgboye","year":"2022","unstructured":"Bamgboye MA, Herold KG, Vieira DCO, Traficante MK, Rogers PJ, Ben-Johny M, et al. CaV1.2 channelopathic mutations evoke diverse pathophysiological mechanisms. J Gen Physiol. 2022;154. e202213209.","journal-title":"J Gen Physiol"},{"key":"2178_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2022.109271","volume":"220","author":"JL Sanderson","year":"2022","unstructured":"Sanderson JL, Freund RK, Castano AM, Benke TA, Dell\u2019Acqua ML. The CaV1.2 G406R mutation decreases synaptic inhibition and alters L-type Ca2+ channel-dependent LTP at hippocampal synapses in a mouse model of Timothy Syndrome. Neuropharmacology. 2022;220. 109271.","journal-title":"Neuropharmacology"},{"key":"2178_CR50","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.51037","volume":"8","author":"G Panagiotakos","year":"2019","unstructured":"Panagiotakos G, Haveles C, Arjun A, Petrova R, Rana A, Portmann T, et al. Aberrant calcium channel splicing drives defects in cortical differentiation in Timothy syndrome. eLife. 2019;8. e51037.","journal-title":"eLife"},{"key":"2178_CR51","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.stem.2021.11.011","volume":"29","author":"F Birey","year":"2022","unstructured":"Birey F, Li M-Y, Gordon A, Thete MV, Valencia AM, Revah O, et al. Dissecting the molecular basis of human interneuron migration in forebrain assembloids from Timothy syndrome. Cell Stem Cell. 2022;29:248\u2013264.e7.","journal-title":"Cell Stem Cell"},{"key":"2178_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2020.101820","volume":"191","author":"E Servili","year":"2020","unstructured":"Servili E, Trus M, Sajman J, Sherman E, Atlas D. Elevated basal transcription can underlie Timothy channel association with autism related disorders. Prog Neurobiol. 2020;191. 101820.","journal-title":"Prog Neurobiol"},{"key":"2178_CR53","doi-asserted-by":"publisher","first-page":"112a","DOI":"10.1016\/j.bpj.2023.11.794","volume":"123","author":"KG Herold","year":"2024","unstructured":"Herold KG, Bamgboye MA, Vieira DCO, Brown S, DiSilvestre D, Owoyemi JO, et al. Exploring the role of CaV1.2 dysfunction in the development of autism spectrum disorder using iPSC-derived neurons. Biophys J. 2024;123:112a.","journal-title":"Biophys J"},{"key":"2178_CR54","doi-asserted-by":"publisher","unstructured":"Ferron L, Zamponi GW. The road to the brain in Timothy syndrome is paved with enhanced CaV1.2 activation gating. J Gen Physiol. 2022;154. Available from: https:\/\/doi.org\/10.1085\/jgp.202213272","DOI":"10.1085\/jgp.202213272"},{"key":"2178_CR55","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s00424-020-02430-0","volume":"472","author":"A Marcantoni","year":"2020","unstructured":"Marcantoni A, Calorio C, Hidisoglu E, Chiantia G, Carbone E. Cav1.2 channelopathies causing autism: new hallmarks on Timothy syndrome. Pflugers Arch. 2020;472:775\u201389.","journal-title":"Pflugers Arch"},{"key":"2178_CR56","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1124\/mol.108.049981","volume":"75","author":"MJ Sinnegger-Brauns","year":"2009","unstructured":"Sinnegger-Brauns MJ, Huber IG, Koschak A, Wild C, Obermair GJ, Einzinger U, et al. Expression and 1,4-dihydropyridine-binding properties of brain L-type calcium channel isoforms. Mol Pharmacol. 2009;75:407\u201314.","journal-title":"Mol Pharmacol"},{"key":"2178_CR57","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41380-019-0583-1","volume":"25","author":"MB Clark","year":"2019","unstructured":"Clark MB, Wrzesinski T, Garcia AB, Hall NAL, Kleinman JE, Hyde T, et al. Long-read sequencing reveals the complex splicing profile of the psychiatric risk gene CACNA1C in human brain. Mol Psychiatry. 2019;25:37\u201347. 2019 251.","journal-title":"Mol Psychiatry"},{"key":"2178_CR58","doi-asserted-by":"publisher","DOI":"10.1017\/erm.2023.11","volume":"25","author":"C Jiang","year":"2023","unstructured":"Jiang C, Zhang Y. Current updates on arrhythmia within Timothy syndrome: genetics, mechanisms and therapeutics. Expert Rev Mol Med. 2023;25. e17.","journal-title":"Expert Rev Mol Med"},{"key":"2178_CR59","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jacep.2021.09.002","volume":"8","author":"V Dusi","year":"2022","unstructured":"Dusi V, Pugliese L, De Ferrari GM, Odero A, Crotti L, Dagradi F, et al. Left cardiac sympathetic denervation for long QT syndrome. JACC Clin Electrophysiol. 2022;8:281\u201394.","journal-title":"JACC Clin Electrophysiol"},{"key":"2178_CR60","doi-asserted-by":"publisher","first-page":"334","DOI":"10.9794\/jspccs.36.334","volume":"36","author":"H Aoki","year":"2020","unstructured":"Aoki H, \u9752\u6728\u6674\u9999, Hokosaki T, \u927e\u7895\u7adc\u7bc4, Watanabe S, \u6e21\u8fba\u91cd\u6717, et al. \u5168\u30a8\u30af\u30bd\u30f3\u89e3\u6790\u306b\u3088\u308aCACNA1C\u907a\u4f1d\u5b50\u30d0\u30ea\u30a2\u30f3\u30c8\u304c\u540c\u5b9a\u3055\u308c\u305f\u5fc3\u5916\u5408\u4f75\u75c7\u306e\u306a\u3044 (\u975eTimothy\u578b) QT\u5ef6\u9577\u75c7\u5019\u7fa4 (LQT8). Pediatr Cardiol Card Surg. 2020;36:334\u201343. https:\/\/doi.org\/10.9794\/jspccs.36.334.","journal-title":"Pediatr Cardiol Card Surg"},{"key":"2178_CR61","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.yjmcc.2022.10.003","volume":"173","author":"MA Bamgboye","year":"2022","unstructured":"Bamgboye MA, Traficante MK, Owoyemi J, DiSilvestre D, Vieira DCO, Dick IE. Impaired CaV1.2 inactivation reduces the efficacy of calcium channel blockers in the treatment of LQT8. J Mol Cell Cardiol. 2022;173:92\u2013100.","journal-title":"J Mol Cell Cardiol"},{"key":"2178_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52885-3","volume":"15","author":"M Matsui","year":"2024","unstructured":"Matsui M, Lynch LE, Distefano I, Galante A, Gade AR, Wang H-G, et al. Multiple beta cell-independent mechanisms drive hypoglycemia in Timothy syndrome. Nat Commun. 2024;15. 8980.","journal-title":"Nat Commun"},{"key":"2178_CR63","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1159\/000535221","volume":"121","author":"A Matthews","year":"2024","unstructured":"Matthews A, Timothy K, Golden A, Gonzalez Corcia MC. International cohort of neonatal Timothy syndrome. Neonatology. 2024;121:388\u201395.","journal-title":"Neonatology"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-026-02178-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-026-02178-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-026-02178-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T12:03:51Z","timestamp":1793966631000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-026-02178-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":63,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["2178"],"URL":"https:\/\/doi.org\/10.1038\/s41431-026-02178-8","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]},"assertion":[{"value":"5 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Supplementary file contained an earlier version of the presented information and has been replaced.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"EMT is a full-time employee of Boehringer Ingelheim. Prior to her move into industry, she was in receipt of unrestricted research grants from J&J Innovation and from Boehringer Ingelheim and Biogen, via the Psychiatry Consortium of the Medicines Discovery Catapult. She also provided consultancy to Boehringer Ingelheim and ONO Pharma. She reports no conflict of interest with the current manuscript. The remaining authors declare that they have no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}